Summary
Three major New Zealand medicinal cannabis companies—Helius Therapeutics, Green Leaf Group, and Elysian Group—are planning a merger to create a single entity named Helius Health, pending shareholder approval by the end of June. This strategic move aims to reshape the country’s medicinal cannabis landscape, which has faced numerous closures and challenges in recent years. Helius Therapeutics is notable for being New Zealand’s first certified Good Manufacturing Practices (GMP) medicinal cannabis company, while Green Leaf Group and Elysian Group operate specialized clinics Cannabis Clinic and CannaPlus+.
